Cargando…

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy

Optimal patient selection for cardiac resynchronization therapy is crucial. There are several concerns that allow to better clarify the association between the ischemic etiology of heart failure and the response to cardiac resynchronization therapy. The type of ischemic coronary disease has an impac...

Descripción completa

Detalles Bibliográficos
Autor principal:	Imamura, Teruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143928/ https://www.ncbi.nlm.nih.gov/pubmed/32143409 http://dx.doi.org/10.3390/medicina56030110

Ejemplares similares

Impact of S-Wave Amplitude in Right Precordial Leads on Improvement in Mitral Regurgitation following Cardiac Resynchronization Therapy
por: Kataoka, Naoya, et al.
Publicado: (2022)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Prolonged PR Interval and Outcome in Cardiac Resynchronization Therapy
por: Kewcharoen, Jakrin, et al.
Publicado: (2019)

Detailed Pathophysiology of Ischemic Colitis Following Plasma Donation
por: Izumida, Toshihide, et al.
Publicado: (2020)

Analysis of tricuspid regurgitation improvement following cardiac resynchronization therapy
por: Ahmad, Syed Yousaf, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

A Simple Predictive Marker in Cardiac Resynchronization Therapy Recipients: Prominent S-Wave in Right Precordial Leads
por: Kataoka, Naoya, et al.
Publicado: (2021)

Association between global longitudinal strain and clinical outcomes following COVID‐19 infection
por: Imamura, Teruhiko
Publicado: (2022)

How to Improve the Cardiac Function and Clinical Outcomes in Patients with Heart Failure with a Mid-range Ejection Fraction
por: Imamura, Teruhiko
Publicado: (2021)

Analysis of tricuspid regurgitation improvement following cardiac resynchronization therapy—Authors’ reply
por: Stassen, Jan, et al.
Publicado: (2023)

Clinical Implication of Korean Dry Sauna Therapy
por: Imamura, Teruhiko
Publicado: (2021)

Clinical Implication of Ivabradine Administration Before Non-Cardiac Surgery
por: Imamura, Teruhiko
Publicado: (2021)

Detailed association between the etiologies of heart failure and occurrence of sleep‐disordered breathing
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Impact of Etiology on the Outcomes in Heart Failure Patients Treated with Cardiac Resynchronization Therapy: A Meta-Analysis
por: Chen, Yanmei, et al.
Publicado: (2014)

How to Increase the Rate of Optimal Medical Therapy following Acute Myocardial Infarction
por: Imamura, Teruhiko
Publicado: (2020)

QRS narrowing and prediction of res-ponse to cardiac resynchronization therapy
por: Uçar, Fatih Mehmet
Publicado: (2018)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Right ventricular dysfunction predicts clinical outcomes following cardiac resynchronization
por: Alpendurada, Francisco, et al.
Publicado: (2011)

Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery
por: Horie, Kotaro, et al.
Publicado: (2023)

Current clinical practice of cardiac resynchronization therapy in Turkey: Reflections from Cardiac Resynchronization Therapy Survey-II
por: Koçyiğit, Duygu, et al.
Publicado: (2020)

Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis
por: Chen, Jian-Shu, et al.
Publicado: (2018)

Clinical implication of device-based algorithm that optimize atrioventricular delay during cardiac resynchronization therapy: author’s reply
por: Ikeda, Yoshifumi, et al.
Publicado: (2022)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Follow-up of Cardiac Fabry Disease Treated by Cardiac Resynchronization Therapy
por: Fukuda, Yuko, et al.
Publicado: (2017)

How to Demonstrate the Impact of Cardiac Rehabilitation on Cardio-renal Protection
por: Imamura, Teruhiko
Publicado: (2019)

Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy
por: Alpendurada, Francisco, et al.
Publicado: (2011)

Cardiac Resynchronization Therapy in Children
por: Batra, Anjan S, et al.
Publicado: (2009)

Advances in Cardiac Resynchronization Therapy
por: Jafferani, Asif, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Pediatrics
por: Hill, Allison C., et al.
Publicado: (2018)

Cardiac Resynchronization Therapy Vegetations
por: Hamada, Abdel Haleem Shawky, et al.
Publicado: (2023)

Clinical implication of ambulatory milrinone therapy in patients with advanced heart failure
por: Nakagawa, Yuri, et al.
Publicado: (2022)

Late Outcomes of Pediatric and Congenital Heart Disease Patients Following Cardiac Resynchronization Therapy
por: Ahn, Jeong Eun, et al.
Publicado: (2022)

Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy
por: Wouters, Philippe C, et al.
Publicado: (2022)

Cardiac magnetic resonance defines mechanisms of sex-based differences in outcomes following cardiac resynchronization therapy
por: Bivona, Derek J., et al.
Publicado: (2022)

Volumetric Response beyond Six Months of Cardiac Resynchronization Therapy and Clinical Outcome
por: van ’t Sant, Jetske, et al.
Publicado: (2015)

Factors associated with procedure‐related cardiac tamponade
por: Kataoka, Naoya, et al.
Publicado: (2023)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n9eb5sfhg2gj5rtcpp832fhlgc